London UK, 21 October 2022 – Cutting edge UK lab automation provider, Automata, has appointed Brands2Life as its communications agency. Automata is one of the life sciences industry’s leading robotics and automation companies, supporting research and development labs across synthetic biology, drug discovery and molecular biology to accelerate science. From the speed and accuracy of diagnostics, through to the development of lab grown meat.
Centred around enabling lab automation to unlock human potential, Automata relieves scientists from repetitive tasks so that they can focus on the science. It enables customers, large and small – including specific NHS Trusts; a leading cancer research and treatment facility in the UK; and prominent biomedical research and clinical trial institutes – to run smarter processes and deliver faster, more accurate outcomes.
Brands2Life’s communications programme will raise awareness of Automata’s lab automation platform and its role in empowering the life sciences industry to reduce manual workloads, while upscaling lab capacity. The programme will also focus on demonstrating the value of Automata’s solutions for the biotech investment community and support growth into new markets, drawing on an integrated proactive press office including news, customer storytelling, executive profiling, thought leadership, speaker opportunities and campaign activation.
“We needed a communications partner that understands how to make our message and proposition stand out in a crowded UK life sciences market, and tell complex, technical stories in a creative and engaging way. The Brands2Life team’s impressive experience and deep knowledge of the sector shone through, and I have every confidence that they will deliver a proactive programme that will enable us to tell the Automata story to as wide an audience as possible.”
Karen Cooper, Automata’s PR and Communications Lead
“The life sciences technology space is incredibly exciting, with so much innovation and potential, and we are thrilled to be working with another of the sector’s pioneers. Automata is delivering important work for the life sciences industry and we’re looking forward to bringing its compelling proposition to life using our Better Stories, Bigger Impact approach.”
Kate Smith, Brands2Life’s Deputy Managing Director of Business & Technology and Life Science lead
Automata joins Brands2Life’s growing life sciences, robotics and automation portfolio, alongside Benchling, UiPath, Universal Robots and Veeva Systems.